This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Centene (CNC) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of 31.25% and 2.50%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Centene (CNC) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Centene's (CNC) Q3 results are likely to reflect benefits from growing revenues and improving membership.
Are Investors Undervaluing Centene (CNC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
6 Low Price-to-Book Stocks That May Prove to be Solid Bets
by Kinjel Shah
When it comes to valuation metrics, though P/E and P/S are the first choices, the P/B ratio is also emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
Give Your Investing Power a Boost With 4 Low P/CF Stocks
by Sumit Singh
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Centene Corporation (CNC), Atlas Corp. (ATCO), Spectrum Brands (SPB) and Tecnoglass (TGLS) boast low P/CF ratio.
Centene (CNC) Reports Next Week: What You Should Expect
by Zacks Equity Research
Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CNC or UNH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CNC vs. UNH: Which Stock Is the Better Value Option?
Humana (HUM) Expands in Tennessee to Boost Medicare Business
by Zacks Equity Research
Humana (HUM) expands Medicare Advantage in 31 rural counties of the Knoxville, Memphis, Nashville regions as well as drives benefits for veterans.
Humana Adds Retail Pharmacies to Medicare Part D Network
by Zacks Equity Research
Humana (HUM) adds Kroger Health and its chain of pharmacies to its preferred stand-alone Medicare Part D pharmacy network, to be effective 2021.
Cigna Set to Grab a Bigger Pie of Medicare Advantage Business
by Zacks Equity Research
Cigna's (CI) Medicare Advantage expansion in new counties and states with attractive prices and a suite of product and service offerings holds promise to widen its market share.
UnitedHealth Expands Offers to Tap Medicare Advantage Market
by Zacks Equity Research
UnitedHealth's (UNH) Medicare Advantage expansion in new counties and states with attractive price and a slew of product and service offerings to grow its market share.
Humana Expands Medicare Plans to Boost New Jersey Footprint
by Zacks Equity Research
Humana's (HUM) 2021 Medicare Advantage plans will not only expand its presence in New Jersey but also provide improved health outcomes.
Top Ranked Growth Stocks to Buy for October 9th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, October 9th
Humana's (HUM) MA Members Gain From Better Health Outcomes
by Zacks Equity Research
Humana's (HUM) individual Medicare Advantage patients enjoy value-based heathcare at reasonable costs.
Centene's 2021 Medicare Plans to Strengthen U.S. Footprint
by Zacks Equity Research
Centene's (CNC) 2021 health plans will not only expand its presence by 30% in the United States but also provide improved health outcomes for its members.
Humana, FMCNA Expand Services for Better Health Outcomes
by Zacks Equity Research
Humana (HUM) expands agreement with Fresenius Medical Care North America to provide better healthcare for Humana Medicare Advantage and commercial members with CKD and ESRD.
3 Low Price-to-Book Stocks to Build Your Portfolio in October
by Kinjel Shah
P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.
Humana Ties Up to Offer Better Healthcare in Colorado Springs
by Zacks Equity Research
Humana (HUM) partners Centura Health in Colorado Springs to dispense high-quality in-network medical care for Humana Medicare Advantage members.
Is Centene (CNC) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3 Low Price-to-Cash Flow Stocks to Garner Superior Returns
by Sumit Singh
Investing in stocks based on value analysis is generally considered one of the best practices. In value investing, investors pick stocks that are usually cheap but fundamentally sound.
Encompass Health Offers Senior Unsecured Notes Worth $400M
by Zacks Equity Research
Encompass Health (EHC) exhibits prudence by issuing senior notes amid a low interest rate environment to procure funds.
Humana Ties Up to Provide Improved Healthcare in Chicago
by Zacks Equity Research
Humana (HUM) partners Rush Health to offer in-network medical care in the Chicago region for Humana Medicare Advantage members.
Molina Healthcare to Buy Affinity Health Plan for $380 Million
by Zacks Equity Research
Molina Healthcare (MOH) to purchase Affinity Health Plan's assets to boost its capabilities and enhance its portfolio in the process.
Here's Why You Should Hold Centene (CNC) in Your Portfolio
by Zacks Equity Research
Riding high on rising revenues and strategic initiatives, Centene (CNC) holds potential to reap benefits for investors.
Humana Ties Up to Provide Improved Medical Care in Ohio
by Zacks Equity Research
Humana (HUM) partners The Ohio State University Wexner Medical Center to provide in-network healthcare for Humana Medicare Advantage members.